Search Within

Wungki Park

Formats
  1. Meeting Abstract (54)
  2. Journal Article (36)
  3. Review (5)
  4. Correspondence (3)
  5. Editorial (3)
Groups
  1. CTCR Scholars (101)
  2. Center for Pancreatic Cancer Research (101)
  3. Department of Medicine (101)
  4. Gastrointestinal Oncology Service (101)
  5. MSK Grad Students (101)
  6. Master of Science in Clinical and Translational Cancer Research (101)

More Groups

People
  1. Eileen O'Reilly (74)
  2. Anna Varghese (39)
  3. Kenneth Yu (35)
  4. Joanne Chou (26)
  5. William Jarnagin (25)
  6. Alice Wei (24)

More People

Years
  1. 2025 (10)
  2. 2024 (27)
  3. 2023 (18)
  4. 2022 (12)
  5. 2021 (11)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Journal for ImmunoTherapy of Cancer (9)
  3. Annals of Oncology (5)
  4. Annals of Surgical Oncology (5)
  5. JCO Precision Oncology (4)
  6. JNCI: Journal of the National Cancer Institute (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Biomed Central Ltd (9)
  3. Oxford University Press (9)
  4. Springer (7)
  5. American Medical Association (5)
  6. Elsevier Inc. (5)

More Publishers

Results (101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    Messersmith, W.; Rasco, D.; De Bono, J.; Wang-Gillam, A.; Park, W.; Nickle, D.; Galkin, A.; Ferguson, B.; Carter, L.; Zhou, L.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Preliminary results from Keynote-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors
    Meeting Abstract

    Bendell, J.; Messersmith, W.; Rasco, D.; Wang-Gillam, A.; Park, W.; Zhou, L.; Carter, L.; Bruey, J. M.; Li, J.; Ferguson, B.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer
    Meeting Abstract

    Bortone, D.; Vensko, S.; Entwistle, S.; Cogdill, A.; Monette, A.; Najjar, Y.; Sweis, R.; Tschernia, N.; Wennerberg, E.; Bommareddy, P.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase I/II study of GB1275, a first-in-class oral CD11b modulator, alone, and combined with pembrolizumab in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (KEYNOTE-A36)
    Meeting Abstract

    Rasco, D. W.; Bendell, J. C.; Wang-Gillam, A.; Park, W.; O'Reilly, E. M.; Zhou, L.; Galkin, A.; Carter, L. L.; Nickle, D.; Li, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in hepatopancreaticobiliary (HPB) cancers
    Meeting Abstract

    Park, W.; Sokol, E.; Chen, J.; Yu, K. H.; Khalil, D.; Harding, J. J.; El Dika, I. H.; Riaz, N.; Abou-Alfa, G. K.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: A pooled exploratory analysis from a global cohort
    Journal Article

    Naqash, A. R.; Ricciuti, B.; Owen, D. H.; Florou, V.; Toi, Y.; Cherry, C.; Hafiz, M.; De Giglio, A.; Muzaffar, M.; Patel, S. H.; more...
    Cancer Immunology, Immunotherapy (2020)

    Fulltext@MSK | Save
  • Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
    Journal Article

    McIntyre, C. A.; Lawrence, S. A.; Richards, A. L.; Chou, J. F.; Wong, W.; Capanu, M.; Berger, M. F.; Donoghue, M. T. A.; Yu, K. H.; Varghese, A. M.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Reply to N. Fazio
    Correspondence

    O'Reilly, E. M.; Park, W.; Kelsen, D. P.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection
    Journal Article

    Park, W.; Chen, J.; Chou, J. F.; Varghese, A. M.; Yu, K. H.; Wong, W.; Capanu, M.; Balachandran, V.; McIntyre, C. A.; El Dika, I.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Young-onset pancreas cancer (PC) in patients less than or equal to 50 years old at Memorial Sloan Kettering (MSK): Descriptors, genomics, and outcomes
    Meeting Abstract

    Varghese, A. M.; Singh, I.; Singh, R. R.; Capanu, M.; Chou, J. F.; Wong, W.; Stadler, Z. K.; Salo-Mullen, E. E.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save